These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017]. Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191 [TBL] [Abstract][Full Text] [Related]
44. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Polyzos SA; Kountouras J; Mantzoros CS Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373 [TBL] [Abstract][Full Text] [Related]
45. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897 [TBL] [Abstract][Full Text] [Related]
47. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. Chen G; Ni Y; Nagata N; Xu L; Ota T Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875 [TBL] [Abstract][Full Text] [Related]
48. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863 [TBL] [Abstract][Full Text] [Related]
49. Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Wong T; Wong RJ; Gish RG Gastroenterol Hepatol (N Y); 2019 Feb; 15(2):83-89. PubMed ID: 31011302 [TBL] [Abstract][Full Text] [Related]
50. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Hossain N; Kanwar P; Mohanty SR Gastroenterol Res Pract; 2016; 2016():7109270. PubMed ID: 27006654 [TBL] [Abstract][Full Text] [Related]
51. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012. McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B Surg Obes Relat Dis; 2018 Jan; 14(1):74-80. PubMed ID: 29055669 [TBL] [Abstract][Full Text] [Related]
52. Non-alcoholic fatty liver disease: The diagnosis and management. Abd El-Kader SM; El-Den Ashmawy EM World J Hepatol; 2015 Apr; 7(6):846-58. PubMed ID: 25937862 [TBL] [Abstract][Full Text] [Related]
56. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? Budd J; Cusi K Am J Med; 2020 May; 133(5):536-543. PubMed ID: 32017891 [TBL] [Abstract][Full Text] [Related]
57. Molecular pathways of nonalcoholic fatty liver disease development and progression. Bessone F; Razori MV; Roma MG Cell Mol Life Sci; 2019 Jan; 76(1):99-128. PubMed ID: 30343320 [TBL] [Abstract][Full Text] [Related]
59. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078 [TBL] [Abstract][Full Text] [Related]
60. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Satapathy SK; Sanyal AJ Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]